Growth Metrics

Assembly Biosciences (ASMB) Change in Acquisitions & Divestments (2016 - 2025)

Assembly Biosciences has reported Change in Acquisitions & Divestments over the past 11 years, most recently at $32.8 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $32.8 million for Q4 2025, down 4.09% from a year ago — trailing twelve months through Dec 2025 was $116.4 million (down 10.92% YoY), and the annual figure for FY2025 was $116.4 million, down 10.92%.
  • Change in Acquisitions & Divestments for Q4 2025 was $32.8 million at Assembly Biosciences, up from $22.7 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for ASMB hit a ceiling of $95.9 million in Q2 2021 and a floor of -$86.4 million in Q3 2021.
  • Median Change in Acquisitions & Divestments over the past 5 years was $22.7 million (2025), compared with a mean of $21.7 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 287.93% in 2021 and later skyrocketed 900.0% in 2022.
  • Assembly Biosciences' Change in Acquisitions & Divestments stood at -$86.4 million in 2021, then skyrocketed by 170.56% to $61.0 million in 2022, then crashed by 69.34% to $18.7 million in 2023, then surged by 82.89% to $34.2 million in 2024, then dropped by 4.09% to $32.8 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $32.8 million (Q4 2025), $22.7 million (Q3 2025), and $34.5 million (Q2 2025) per Business Quant data.